MiR-409-3p通过向Rab10来调节THP-1的增殖和亡
Wenjie Xie1, Zhichao Wang1, Xiaofang Guo1
1Department of Clinical Laboratory, The Affiliated Hospital of Qingdao University, 16 Jiangsu Road, Qingdao 266003, China.
Leukemia research
|July 12, 2023
概括
在急性髓性白血病 (AML) 中,MicroRNA-409-3p通过抑制细胞增殖和促进细胞亡,起到瘤抑制作用. 这种微RNA直接针对Rab10,为AML治疗提供了潜在的新疗法策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 基因规则 基因规则
背景情况:
- 微RNAs (miRNAs) 涉及急性髓性白血病 (AML) 发病,但它们的具体作用尚未完全理解.
- 我们团队先前的研究表明,AML骨髓中的miR-409-3p表达下调.
- 在AML中,miR-409-3p的瘤抑制功能和分子机制在很大程度上是未知的.
研究的目的:
- 调查miR-409-3p在AML发展中的功能意义.
- 阐明 miR-409-3p. 的瘤抑制活性背后的分子机制.
- 根据miR-409-3p的功能来确定AML的潜在治疗点.
主要方法:
- 在THP-1 AML细胞中对miR-409-3p表达的定量评估.
- 使用agomiR-409-3p转染的miR-409-3p过度表达.
- Rab10作为miR-409-3p的直接标基因的验证.
- 在体外对细胞增殖,细胞亡和蛋白质表达 (Bcl-2,Bax) 的评估.
- 在异种移植小鼠模型中评估瘤生长.
主要成果:
- 在THP-1细胞中,miR-409-3p的表达显著下降.
- 过度表达miR-409-3p抑制了THP-1细胞增殖和增加了细胞亡.
- Rab10被确定为miR-409-3p的直接标,其下调模仿了miR-409-3p过度表达的影响.
- miR-409-3p调节了与亡有关的蛋白质的表达,降低了Bcl-2的调节,并提高了Bax的调节.
- 在体内研究表明,与miR-409-3p过度表达细胞的小鼠的瘤重量和大小减少.
结论:
- miR-409-3p通过直接向Rab10,在AML中表现出瘤抑制活性.
- 在AML中,miR-409-3p/Rab10轴影响细胞增殖和细胞亡.
- 这一途径代表了AML治疗的潜在治疗标.
相关概念视频
Rab Proteins
4.0K
Rab proteins constitute the largest family of monomeric GTPases, of which 70 members are present in humans. Rab proteins and their effectors regulate consecutive stages of vesicle transport such as vesicle transport, docking, and fusion to the correct recipient membrane.
Rab proteins switch between a cytosolic, GDP-bound inactive state and a membrane-anchored, GTP-bound active state. By themselves, Rabs show slow rates of GDP/GTP exchange and GTP hydrolysis. Thus, Rab proteins are considered...
Rab proteins switch between a cytosolic, GDP-bound inactive state and a membrane-anchored, GTP-bound active state. By themselves, Rabs show slow rates of GDP/GTP exchange and GTP hydrolysis. Thus, Rab proteins are considered...
4.0K
PI3K/mTOR/AKT Signaling Pathway
3.7K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.7K
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
TGF - β Signaling Pathway
7.4K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.4K
Negative Regulator Molecules
35.5K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.5K


